The recent surge in capital into specialized pharmaceutical companies, particularly those focusing on novel therapies and complex drug development programs, has fueled what some are calling "High Stakeholder Pharma." https://kallumknps401191.develop-blog.com/47971676/high-roller-pharma-a-speculative-investment